Thiotepa Injection Articles
Europe’s CHMP serves up negative opinion for Ark’s Cerepro and calls for ban on benfluorex drugs, but good news for B-MS, Sanofi, GSK, Novartis
21 December 2009
NEJM warns against breast cancer therapy
8 March 2000
FDA Approval For Immunex' Etoposide
25 March 1996
Lisofylline In Ph III By 2nd Qtr 1995, Says CTI
19 September 1994
Showing 1-4 of 4 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
